Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-078-0 | CAS number: 31923-84-9 1 - 4.5 moles propoxylated
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Gene mutation in bacteria in vitro (OECD 471): negative in S. typhimurium TA 1535, TA 100, TA 1537, TA 98, and TA 102 with and without metabolic activation
Chromosome aberration in mammalian cells in vitro (OECD 743): negative in Chinese hamster lung fibroblasts (V79) with and without metabolic activation
Gene mutation in mammalian cells in vitro (OECD 476): negative in Chinese hamster lung fibroblasts (V79) with and without metabolic activation
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 5 Feb - 11 Dec 2009
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Ministerium für Arbeit, Gesundheit und Soziales des Landes Nordrhein-Westfalen, Düsseldorf, Germany
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- mutant histidine gene
- Species / strain / cell type:
- other: S. typhimurium TA 1535, TA 100, TA 1537, TA 98, and TA 102
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix was made from the livers of male Sprague Dawley rats, which received a single intraperitoneal injection of 500 mg/kg bw Aroclor 1254, dissolved in corn oil, 5 days prior to sacrifice. The S9 mix comprised 10% S9 fraction supplemented with cofactors.
- Test concentrations with justification for top dose:
- plate incorporation assay:
0, 50, 158, 500, 1581, 5000 µg/plate with and without S9 mix
preincubation assay:
0, 50, 158, 500, 1581, 5000 µg/tube with and without S9 mix - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: deionised water (test item and positiv control Mytomycin C); DMSO (other positive controls)
- Justification for choice of solvent/vehicle: test item formed a clear colorless solution - Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Remarks:
- Na-azide (only TA 1535), nitrofurantoin (only TA 100), 4-nitro-1,2-phenylene diamine (TA 1537 and TA 98), mitomycin C (only TA 102 in plate incorporation assay), cumene hydroperoxide (only TA 102 in preincubation assay), 2-aminoanthracene
- Evaluation criteria:
- A reproducible and dose-related increase in mutant counts of at least one strain is considered to be a positive result. For TA 1535, TA 100 and TA 98 this increase should be about twice that of negative controls, whereas for TA 1537, at least a threefold increase should be reached. For TA 102 an increase of about 100 mutants should be reached. Otherwise, the result is evaluated as negative. However, these guidelines may be overruled by good scientific judgment.
- Statistics:
- no statistics perfomed; evaluation based on criteria mentioned above.
- Key result
- Species / strain:
- other: S. typhimurium TA 1535, TA 100, TA 1537, TA 98, and TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Remarks:
- Total bacteria counts remained unchanged and no inhibition of growth was observed.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- In the plate incorporation test, none of the five strains showed a dose-related and/or biologically relevant increase in mutant counts over those of the negative controls. This applied both to the tests with and without S9 mix and was confirmed by the results of the preincubation trials.
- Conclusions:
- The test substance was considered to be non-mutagenic without and with S9 mix in the plate incorporation as well as in the preincubation modification tested in Salmonella typhimurium strains TA 1535, TA 100, TA, 1537, TA 98, and TA 102.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 10 Aug - 3 Dec 2009
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5375 - In vitro Mammalian Chromosome Aberration Test
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Ministerium für Arbeit, Gesundheit und Soziales des Landes Nordrhein-Westfalen, Düsseldorf, Germany
- Type of assay:
- in vitro mammalian chromosome aberration test
- Target gene:
- not applicable
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9: isolated from Arochlor 1254 male Sprague Dawley rat liver microsomal fraction
- Test concentrations with justification for top dose:
- 4 h treatment time, 18 h harvest time (+/- S-9 mix):
600, 1200 and 2400 µg/mL
18 h treatment time, 18 h harvest time (- S-9 mix):
600, 1200, 1600, 2000, 2400 µg/mL - Vehicle / solvent:
- deionised water
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: see below
- Details on test system and experimental conditions:
- Positive controls:
without S9 mix: Mitomycin C, 0.1 µg/mL (for 4 h treatment) and 0.03 µg/mL (for 18 h treatment)
with S9 mix: Cyclophosphamide, 2 µg/mL
Chromosomes were prepared 18 and 30 h (for 4 h treatment) or 18 h (for 18 h treatment) after start of treatment with test substance. The treatment interval was 4 h with and without metabolic activation and 18 h without metabolic activation. In each experimental group two parallel cultures were set up. Per culture 100 metaphases were scored for structural chromosomal aberrations. Polyploid metaphases were recorded. - Evaluation criteria:
- An increased incidence of gaps of both types without concomitant increase of other chromosomal aberration types was not considered as indication of a clastogenic effect.
A test was considered positive, if there was a relevant and statistically significant increase in the aberration rate.
A test was considered negative, if there was no such increase at any time interval.
A test was also considered negative, if there were statistical significant values, which were, however, within the range of historical negative controls.
In addition, a test was considered equivocal if there was an increase of aberrant metaphases above the range of attached historical negative controls, provided the increase was not significant and the result of the negative control was not closely related to the data of the respective treatment group. A test was also considered equivocal, if its result was implausible. - Statistics:
- Statistical significance at the 5% level (p<0.05) was evaluated by means of the chi-square test. Evaluation was performed only for cells carrying aberrations exclusive gaps.
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- +S-9 mix: >= 1200 µg/mL (4 h treatment); 2400 µg/mL (18 h treatment); +S-9 mix: no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- - Effects on pH: none
- Effects of osmolality: no effects
- Water solubility: soluble up to 300 mg/mL
- Precipitation: none - Conclusions:
- The test substance is considered not to be clastogenic in mammalian cells based on an in vitro chromosome aberration test with Chinese hamster V79 cells in the presence and absence of S9 mix.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Hessisches Ministerium für Umwelt, Energie, Landwirtschaft und Verbraucherschutz, Wiesbaden, Germany
- Type of assay:
- in vitro mammalian cell gene mutation test using the Hprt and xprt genes
- Target gene:
- HPRT locus
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- Type and identity of media: MEM (minimal essential medium; SEROMED, Berlin, Germany) supplemented with 10 % fetal calf serum
- Metabolic activation:
- with and without
- Metabolic activation system:
- Phenobarbital/ß-naphthoflavone induced male Wistar rat liver S9 mix
- Test concentrations with justification for top dose:
- Experiment I:
without S9 mix: 150, 300, 600, 1200, 2400 µg/mL
with S9 mix: 150, 300, 600, 1200, 2400 µg/mL
Experiment II
without S9 mix: 300, 600, 1200, 1800, 2400 µg/mL
with S9 mix: 300, 600, 1200, 1800, 2400 µg/mL
In both main experiments the cultures at the lowest concentrations with and without metabolic activation were not continued since a minimum of only four analysable concentrations is required by the guideline. - Vehicle / solvent:
- Vehicle(s)/solvent(s) used: deionised water
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- deionised water
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: ethylmethanesulfonate (EMS, 0.15 mg/mL, -S9); dimethylbenzanthracene (DMBA, 1.1 µg/mL, +S9)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: 4 h
- Expression time (cells in growth medium): 7 days
NUMBER OF REPLICATIONS: 2
DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency - Evaluation criteria:
- A test item is considered as positive if it induces either a concentration-related increase of the mutant frequency or a reproducible and positive response at one of the test points.
A test item producing neither a concentration-related increase of the mutant frequency nor a reproducible positive response at any of the test points is considered non-mutagenic in this system.
A positive response is described as follows:
A test item is considered as mutagenic if it reproducibly induces a mutation frequency that is three times above the spontaneous mutation frequency at least at one of the concentrations in the experiment.
The test item is considered as mutagenic if there is a reproducible concentration-related increase of the mutation frequency. Such evaluation may be considered also in the case that a threefold increase of the mutant frequency is not observed.
However, in a case by case evaluation this decision depends on the level of the corresponding solvent control data. If there is by chance a low spontaneous mutation rate in the range normally found (0.6 – 31.7 mutants per 10E6 cells) a concentration-related increase of the mutation within this range has to be discussed. The variability of the mutation rates of solvent controls within all experiments of this study was also taken into consideration. - Statistics:
- A linear regression (least squares) was performed to assess a possible dose-dependent increase of mutant frequencies using SYSTAT®11 (SYSTAT Software, Inc., 501, Ganal Boulevard, Suite G, Richmond, GA 94804, USA) statistics software. The number of mutant colonies obtained for the cultures treated with the test item were compared to the solvent controls. A trend is judged as significant whenever the p-value (probability value) is below 0.05. However, both, biological and statistical significance were considered together.
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Conclusions:
- The test substance did not induce mutagenic effects in the in vitro gene mutation assay (HPRT test) with Chinese hamster V79 cells in the presence and absence of a metabolic activation system.
Referenceopen allclose all
Additional data supporting the information provided are attached as pdf documents below under 'Attached background material'.
Additional data supporting the information provided are attached as pdf documents below under 'Attached background material'.
Additional data supporting the information provided are attached as pdf documents below under 'Attached background material'.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Gene mutation in bacteria in vitro
In an in vitro assessment of the mutagenic potential of ethane-1,2-diol, propoxylated (CAS No.31923-84-9, EC No. 500-078-0) in bacteria according to OECD guideline 471 under GLP conditions (rel 1-key, Ames, OECD 471, Bayer Schering Pharma, 2010b, T7080063), histidine-dependent auxotrophic mutants of Salmonella typhimurium strains TA 1535, TA 100, TA 1537, TA 98, and TA 102 were exposed to the test substance diluted in deionised water. Deionised water was also used as a negative control. Two independent experiments were performed in the presence and absence of liver preparations (S9 mix) from rats treated with aroclor 1254. The first test was a standard plate incorporation assay; the second included a pre-incubation stage. Concentrations of 0, 50, 158, 500, 1581, 5000 µg/plate with and without S9 mix were tested in both experiments. No signs of toxicity were observed towards the tester strains in either mutation test. No evidence of mutagenic activity was seen at any concentration of the test substance in either mutation test, in the absence or presence of metabolic activation. The concurrent positive controls demonstrated the sensitivity of the assay and the metabolising activity of the liver preparations. It is concluded that ethane-1,2-diol, propoxylated showed no evidence of mutagenic activity in this bacterial system under the test conditions used.
Chromosome aberration in mammalian cells in vitro
The clastogenic potential of ethane-1,2-diol, propoxylated (CAS No.31923-84-9, EC No. 500-078-0) was evaluated in a chromosome aberration test in vitro according to OECD guideline 473 under GLP conditions (rel 1-key, CA, OECD 473, Bayer Schering Pharma, 2010c, T6080062). Chinese hamster V79 cells were exposed in the absence and in the presence of S9 mix for 4 h to concentrations of 600, 1200 and 2400 µg/mL of the test substance. Cultures of all concentrations were harvested 18 h after the beginning of the treatment. In addition, cells treated with 2400 µg/mL were harvested 30 h after the beginning of the treatment. Without S9 mix an additional experiment was performed using continuous treatment for 18 h, harvest at the same time, and test substance concentrations of 600, 1200, 1600, 2000 and 2400 µg/mL. Based on cytotoxicity test substance concentrations were selected for reading of metaphases. Without S9 mix cytotoxic effects were observed at 1200 µg/mL and above (4 h treatment) and at 2400 µg/mL (18 h treatment). With S9 mix no cytotoxic effects were observed. Precipitation in the medium did not occur. Therefore, concentrations of 600, 1200 and 2400 µg/mL (18 h treatment) were chosen for reading in the absence of S9 mix. All of the cultures harvested 18 h after the beginning of the treatment were included. None of the cultures treated with the test substance in the absence and in the presence of S9 mix showed biologically relevant or statistically significant increased numbers of aberrant metaphases. The positive controls induced clastogenic effects and demonstrated the sensitivity of the test system and the activity of the used S9 mix. Based on this test, ethane-1,2-diol, propoxylated is considered not to be clastogenic in mammalian cells in vitro.
Gene mutation in mammalian cells in vitro
A study according to OECD guideline 476 under GLP conditions was performed to investigate the potential of ethane-1,2-diol, propoxylated (CAS No.31923-84-9, EC No. 500-078-0) to induce gene mutation at the HPRT locus in V79 cells of the Chinese hamster (rel 1-key, HPRT, OECD 476, Harlan CCR, 2009, 1280201). The assay was performed in two independent experiments, using two parallel cultures each. Both experiments were performed with and without liver microsomal activation and a treatment period of 4 h. The highest applied concentration (2400 µg/mL) was equal to a molar concentration of approximately 10 mM. The tested concentrations were as follows: Experiment I: 150, 300, 600, 1200, 2400 µg/mL (experiment I, with and without S9 mix) and 300, 600, 1200, 1800, 2400 µg/mL (experiment II, with and without S9 mix). No precipitation was observed up to the maximal concentration. No substantial and reproducible dose-dependent increase of the mutation frequency was observed in both experiments. Appropriate reference mutagens, used as positive controls, induced a distinct increase in mutant colonies and thus, showed the sensitivity of the test item and the activity of the metabolic activation system. In conclusion it can be stated that under the experimental conditions reported ethane-1,2-diol, propoxylated did not induce gene mutations at the HPRT locus in V79 cells.
Justification for classification or non-classification
The available in vitro data on genetic toxicity with ethane-1,2-diol, propoxylated (CAS No.31923-84-9, EC No. 500-078-0) do not meet the criteria for classification according to Regulation (EC) No. 1272/2008 (CLP) and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
